Which treatment for patent foramen ovale in cryptogenic stroke?

Current Treatment Options in Cardiovascular Medicine

Volumn 7, Issue 3, 2005, Pages 179-185

  Mahé, Isabelle ^a   Caulin, Charles ^b   Bergmann, Jean François ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOGLUTETHIMIDE; AMIODARONE; ANTICOAGULANT AGENT; BENZBROMARONE; BOSENTAN; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIMETIDINE; CISAPRIDE; COLESTYRAMINE; DANAZOL; DIFLUNISAL; DISULFIRAM; ECONAZOLE; FLUCONAZOLE; FLUINDIONE; FLUOROURACIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ITRACONAZOLE; MACROLIDE; MICONAZOLE; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TIBOLONE; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; ANAPHYLAXIS; ASTHMA; BLEEDING; CLINICAL PROTOCOL; DEVICE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MEGADOSE; EDEMA; ELECTROCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOACUSIS; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; STOMACH ULCER; STROKE; URTICARIA;

EID: 27744476402     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-005-0046-7     Document Type: Review

References (16)

1. Di Tullio M, Sacco RL, Gopal A, et al.: Patent foramen ovale as risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461-465.
2. Messe SR, Silverman IE, Kizer JR, et al.: Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 62:1042-1050.
3. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clinic Proc 1984, 59:17-20.
4. Wu LA, Malouf JF, Dearani JA, et al.: Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004, 164:950-956.
5. Cabanes L, Coste J, Derumeaux G, et al.: Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. J Am Soc Echocardiogr 2002, 15:441-446.
6. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-1179.
7. Homma S, Sacco RL, Di Tullio MR, et al.: Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002, 105:2625-2631.
8. Orgera MA, O'Malley PG, Taylor AJ: Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001, 94:699-703.
9. Windecker S, Wahl A, Nedeltchev K, et al.: Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004, 44:750-758.
10. Bogousslavsky J, Garazi S, Jeanrenaud X, et al.: Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with paradoxical Embolism Study Group. Neurology 1996, 46:1301-1305.
11. Krumsdorf U, Ostermayer S, Billinger K, et al.: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004, 43:155-315.
12. Windecker S, Wahl A, Chatterjee T, et al.: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Long-term risk of recurrent thromboembolic events. Circulation 2000, 101:893-898.
13. Baker SS, O'Laughin MP, Jollis JG, et al.: Cost implications of closure of atrial septal defects. Catheter Cardiovasc Interv 2002, 55:83-87.
14. Homma S, Tullio MP, Sacco RL, et al.: Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997, 28:2376-2381.
15. Nendaz M, Sarasin F, Bogousslavsky J: How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure or nothing? Eur Neurol 1997, 37:199-204.
16. Dearani JA, Ugurlu BS, Danielson GK, et al.: Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999, 100(19 suppl):II171-II175.